Sales of GlaxoSmithKline’s (GSK) Avandia products for diabetes dropped 22% because of health concerns about the drug. And the company’s overall reveue missed analyst forecasts.
But, the company announced that it would buy-back almost $25 billion in shares, and extraordinary amount for a company with a $145 billion market cap.
Shares were up 3% in pre-market trading.
Douglas A. McIntyre
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
